ERO vs. NUTX
ERO (Ero Copper Corp) and NUTX (Nutex Health Inc) are both stocks. ERO operates in Copper (Basic Materials), while NUTX operates in Health Information Services (Healthcare). Over the past 3 years, ERO returned 20.87%/yr vs 25.10%/yr for NUTX. At a 0.12 correlation, their price movements are largely independent.
Performance
ERO vs. NUTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ERO achieves a 8.73% return, which is significantly higher than NUTX's -17.93% return.
ERO
- 1D
- -0.68%
- 1M
- 19.13%
- YTD
- 8.73%
- 6M
- 22.40%
- 1Y
- 93.46%
- 3Y*
- 20.87%
- 5Y*
- 5.99%
- 10Y*
- —
NUTX
- 1D
- 1.71%
- 1M
- 11.65%
- YTD
- -17.93%
- 6M
- -13.83%
- 1Y
- -0.38%
- 3Y*
- 25.10%
- 5Y*
- —
- 10Y*
- —
ERO vs. NUTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ERO Ero Copper Corp | 8.73% | 109.87% | -14.63% | 14.84% | -12.42% |
NUTX Nutex Health Inc | -17.93% | 419.47% | 17.37% | -90.53% | -95.25% |
Correlation
The correlation between ERO and NUTX is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Apr 5, 2022 | 0.12 |
Fundamentals
ERO:
$2.80
NUTX:
$19.08
ERO:
11.00
NUTX:
7.08
ERO:
0.12
NUTX:
0.06
ERO:
3.47
NUTX:
0.78
ERO:
$925.20M
NUTX:
$879.95M
ERO:
$394.67M
NUTX:
$417.67M
ERO:
$528.87M
NUTX:
$275.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ERO vs. NUTX — Risk / Return Rank
ERO
NUTX
ERO vs. NUTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ero Copper Corp (ERO) and Nutex Health Inc (NUTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ERO | NUTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.72 | ||
| Sortino ratioReturn per unit of downside risk | +1.50 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.08 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 2.47 | -0.01 | +2.48 |
| Martin ratioReturn relative to average drawdown | 5.46 | -0.01 | +5.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ERO | NUTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.72 | -0.00 | +1.72 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.11 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.54 | -0.45 | +0.99 |
Drawdowns
ERO vs. NUTX - Drawdown Comparison
The maximum ERO drawdown since its inception was -67.17%, smaller than the maximum NUTX drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for ERO and NUTX.
Loading charts...
Drawdown Indicators
| ERO | NUTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.17% | -99.93% | +32.76% |
Max Drawdown (1Y)Largest decline over 1 year | -37.97% | -54.32% | +16.35% |
Max Drawdown (3Y)Largest decline over 3 years | -59.84% | -94.36% | +34.52% |
Max Drawdown (5Y)Largest decline over 5 years | -64.56% | — | — |
Current DrawdownCurrent decline from peak | -19.12% | -97.75% | +78.63% |
Average DrawdownAverage peak-to-trough decline | -27.05% | -97.27% | +70.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.17% | 30.71% | -13.54% |
Volatility
ERO vs. NUTX - Volatility Comparison
Ero Copper Corp (ERO) has a higher volatility of 19.62% compared to Nutex Health Inc (NUTX) at 16.71%. This indicates that ERO's price experiences larger fluctuations and is considered to be riskier than NUTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ERO | NUTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.62% | 16.71% | +2.91% |
Volatility (6M)Calculated over the trailing 6-month period | 42.77% | 66.89% | -24.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.28% | 95.22% | -39.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.38% | 133.27% | -78.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.06% | 133.27% | -74.21% |
Dividends
ERO vs. NUTX - Dividend Comparison
Neither ERO nor NUTX has paid dividends to shareholders.
Financials
ERO vs. NUTX - Financials Comparison
This section allows you to compare key financial metrics between Ero Copper Corp and Nutex Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ERO vs. NUTX - Profitability Comparison
ERO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ero Copper Corp reported a gross profit of 103.33M and revenue of 259.52M. Therefore, the gross margin over that period was 39.8%.
NUTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported a gross profit of 91.73M and revenue of 216.49M. Therefore, the gross margin over that period was 42.4%.
ERO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ero Copper Corp reported an operating income of 90.17M and revenue of 259.52M, resulting in an operating margin of 34.7%.
NUTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported an operating income of 81.27M and revenue of 216.49M, resulting in an operating margin of 37.5%.
ERO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ero Copper Corp reported a net income of 107.26M and revenue of 259.52M, resulting in a net margin of 41.3%.
NUTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported a net income of 46.81M and revenue of 216.49M, resulting in a net margin of 21.6%.
Frequently Asked Questions
ERO and NUTX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ERO has higher volatility (19.62%) compared to NUTX (16.71%). In terms of maximum drawdown, ERO dropped -67.17% vs NUTX's -99.93%.
ERO currently has the higher Sharpe Ratio (1.72 vs -0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ERO and NUTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer